For over a century, scientists believed that antibodies protected us by preventing germs from entering our cells. But what if the true defence isn't at the door but inside the room? 

Researchers at UT Southwestern Medical Center have discovered a significant shift in how the immune system might combat tuberculosis (TB). The team describes what they call a "Trojan Horse Defence"—a tactic that permits the tuberculosis bacterium to enter immune cells before being eliminated from within. 

Tuberculosis, produced by Mycobacterium tuberculosis (Mtb), is still the world's greatest infectious killer. Global predictions indicate that 10.8 million individuals will contract tuberculosis in 2023, with 1.25 million dying. One in every four people worldwide has the bacteria, although only approximately 10% develop active illness. Why is it that 90% of people remain healthy? That riddle has perplexed scientists for decades. 

"This data changes how we think about using the immune system against tuberculosis," stated Dr Lenette Lu, the study's principal author. “Identifying these underlying characteristics… offers insight on how to build antibodies with supernatural activities against TB.” 

Not a shield—but a double agent 

Antibodies are Y-shaped proteins that can identify pathogens. Traditionally, researchers concentrated on the "front" of the antibody, known as the Fab domain, which binds to bacteria or viruses to prevent infection. 

However, just restricting entry has never been effective against tuberculosis. The bacterium has developed to infect macrophages, immune cells that "eat" pathogens. Rather than destroying these cells, tuberculosis regards them as safe lodgings, proliferating peacefully inside. 

Dr. Lu's team discovered that the key is not at the front of the antibody but at the "back end," known as the Fc domain. N-glycans, or small sugar molecules, are attached to this area. These sugars function as a hidden molecular code. 

Certain antibodies that target two key tuberculosis proteins, ESAT-6 and CFP-10, and carry unique sugar patterns on their Fc domain perform a surprising function. They allow tuberculosis to enter macrophages, but the sugar code activates a switch within the cell. This switch activates the macrophage, destroying the bacterium before it can proliferate. 

Simply put, the antibody serves as a double agent, transporting the intruder inside and then setting off an internal trap. 

Why This Matters 

The sole licensed tuberculosis vaccine, Bacillus Calmette-Guérin (BCG), provides little protection, especially in adults. A more effective vaccine might avert an estimated 8.5 million deaths over the next 25 years, saving billions of dollars in healthcare expenditures. 

This new finding implies that future vaccinations may need to induce not just any antibodies, but very specialised "supernatural antibodies" created with exact sugar instructions. 

The findings also help explain the 10% mystery. Individuals who avoid sickness despite exposure may spontaneously create these specifically programmed antibodies. 

High Stakes, Global Impact. 

The implications go beyond theoretical. Texas has one of the highest tuberculosis burdens in the United States, with 1,243 cases reported in 2023 and a tentative 1,266 in 2024, which is greater than the national average. 

The National Institute of Allergy and Infectious Diseases, a branch of the National Institutes of Health in the United States, funded the research.